4.3 Article

High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells

Journal

ONCOTARGET
Volume 8, Issue 12, Pages 19192-19204

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.15163

Keywords

OCT4A; POU5F1; LIN28A; medulloblastoma; aggressiveness

Funding

  1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [FAPESP-CEPID (2013/08028-1), FAPESP (2010/52686-5)]
  2. FAPESP Fellowships [2011/05534-8, 2013/17566-7, 2011/51588-2, 2011/10001-9, 2013/02983-1]
  3. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [309206/2011-1, 444722/2014-9, 573633/2008-8]
  4. Financiadora de Estudos e Projetos (FINEP) [FINEP-CTC (0108057900)]

Ask authors/readers for more resources

Medulloblastoma is a highly aggressive pediatric brain tumor, in which sporadic expression of the pluripotency factor OCT4 has been recently correlated with poor patient survival. However the contribution of specific OCT4 isoforms to tumor aggressiveness is still poorly understood. Here, we report that medulloblastoma cells stably overexpressing the OCT4A isoform displayed enhanced clonogenic, tumorsphere generation, and invasion capabilities. Moreover, in an orthotopic metastatic model of medulloblastoma, OCT4A overexpressing cells generated more developed, aggressive and infiltrative tumors, with tumor-bearing mice attaining advanced metastatic disease and shorter survival rates. Pro-oncogenic OCT4A effects were expression-level dependent and accompanied by distinct chromosomal aberrations. OCT4A overexpression in medulloblastoma cells also induced a marked differential expression of non-coding RNAs, including poorly characterized long non-coding RNAs and small nucleolar RNAs. Altogether, our findings support the relevance of pluripotency-related factors in the aggravation of medulloblastoma traits classically associated with poor clinical outcome, and underscore the prognostic and therapeutic value of OCT4A in this challenging type of pediatric brain cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available